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Implications for rehabilitation  
o Participants who had help from family members to complete activities described 
guilt and shame, highlighting the need for a greater rehabilitation focus on 
maintaining independence. 
o Difficulties with sexual relationships due to prolapse or erectile dysfunction, and 
associated anxieties have indicated a need for greater awareness of these issues 
within primary care. 
o The provision of reliable information and materials is vital, both for healthcare 
professionals and patients, to reduce misinformation and fear. 
o Physiotherapists with knowledge of Joint Hypermobility Syndrome and Ehlers-
Danlos Syndrome Hypermobility Type were cited as sources of support and 
hope, which helped people to cope with and manage their condition.  
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Understanding the psychosocial impact of Joint Hypermobility 
Syndrome and Ehlers-Danlos Syndrome Hypermobility Type: A 
qualitative interview study 
Abstract 
Purpose: Little attention has been paid to psychosocial factors in Joint 
Hypermobility Syndrome and Ehlers-Danlos Syndrome (Hypermobility Type). 
This study sought to identify the psychosocial impact by examining participants’ 
lived experiences; and identify characteristics of effective coping.  
Materials and methods: Adults with Joint Hypermobility Syndrome and Ehlers-
Danlos Syndrome (Hypermobility Type) were invited to discuss their own lived 
experiences and the impact of the condition. All met recognised criteria for 
clinically significant joint hypermobility, and had a self-confirmed diagnosis. The 
transcripts were coded and analysed using inductive thematic analysis.  
Results: 17 participants (14 women, 3 men) purposively selected to broadly 
represent different genders, ages and ethnicities. Analysis identified five key 
themes: healthcare limitations, a lack of awareness of Joint Hypermobility and 
Ehlers-Danlos Syndrome (Hypermobility Type) among healthcare professionals; 
a restricted life; social stigma; fear of the unknown; and ways of coping. 
Conclusions: The results highlight the significant psychosocial impact on 
participants’ lives. Coping approaches identified included acceptance, building 
social networks, learning about joint hypermobility and adapting activities. 
Physiotherapists supported regular exercise. Further research should consider 
potential interventions to improve information provision, address psychological 
support and increase awareness of hypermobility among healthcare professionals.  
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Joint Hypermobility Syndrome (JHS) and Ehlers-Danlos Syndrome, 
Hypermobility Type (EDS-HT) are heritable disorders of connective tissue 
characterised by generalised joint hypermobility, soft tissue laxity and joint pain [1].  
International classification for Ehlers-Danlos Syndromes has recently been revised, with 
the terms Hypermobile Ehlers-Danlos Syndrome (hEDS), and Hypermobility Spectrum 
Disorder (HSD), replacing EDS-HT and JHS respectively [2]. However, as this research 
was conducted prior to the revised nosology, for consistency we will use the combined 
term JHS/EDS-HT, except where authors have used one term specifically. A previous 
diagnosis of JHS/EDS-HT was based on medical and family histories in addition to 
symptoms at clinical presentation, as the genes responsible for JHS/EDS-HT have not 
been identified [3, 4]. The most common form of EDS, EDS-HT (formerly Type III) has 
been considered to be the same as JHS; the terms are used interchangeably throughout 
the literature [3, 4].   
Estimates for the prevalence of JHS/EDS-HT are variable within the literature. 
When examining the prevalence of JHS in patients attending a UK musculoskeletal 
triage clinic in London, 30% of all participants screened were found to meet the 
diagnostic criteria for JHS [5]. Literature estimates the prevalence of EDS as 
approximately 1 in 5000 [6] but due to changes in diagnostic criteria and naming of the 
syndromes over time the actual frequency of JHS/EDS-HT within the population has 
yet to be established [7].  
The effect of JHS/EDS-HT on people's lives is substantial. Fatigue has been 
found to be significantly more prevalent in patients with JHS/EDS-HT, compared to the 
general population [8]. Pain, due to chronic joint pain or injury, can cause severe 
progressive deterioration of physical functioning and quality of life [7, 9]. In an online 
survey of 466 adults, JHS/EDS-HT was found to be associated with a number of 
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comorbid conditions, including anxiety (73%), depression (69%) and fibromyalgia 
(42%) [10].  
A recent review of qualitative literature indicated few studies examining the 
lived experience and resulting psychosocial impact of JHS/EDS-HT on participants 
[11]. In Sweden, Berglund and colleagues [12] interviewed eleven interviewees with 
EDS, recruited from a support group. Results indicated the main theme “living a 
restricted life” comprised participants’ descriptions of living with pain, living with fear, 
feeling stigmatised and experiencing of a lack of support when consulting healthcare 
professionals [12]. In other studies, participants reported being ignored and belittled by 
doctors, being accused of hypochondria or Munchausen's syndrome, or treated as a 
spectacle or objectified [13, 14]. Others reported limited social participation due to 
fatigue, chronic pain or the risk of injury [15]. The impact of JHS/EDS-HT was also felt 
in the workplace, whether needing to work part-time, making adaptations, or taking 
early retirement due to symptoms [16].  
Management of JHS/EDS-HT is primarily focused on physiotherapy and 
exercise [17, 18]. However, qualitative studies examining patients’ views of 
physiotherapy for JHS indicated that referral to physiotherapy services could be difficult 
and time-consuming [17]. Physiotherapists could struggle to know which exercises to 
recommend for JHS/EDS-HT, and recommended exercises could sometimes make joint 
pain worse [17, 19]. 
In order to gain a greater understanding of the multifaceted impact of JHS/EDS-
HT it is necessary to explore a greater number of factors than have previously been 
studied using biomedical approaches. Despite awareness of high levels of anxiety, 
depression and low quality of life associated with JHS/EDS-HT [7, 20, 21] within the 
literature there has been little consideration given to the psychological, social and 
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cognitive impact of JHS/EDS-HT. In addition, a new toolkit for general practitioners to 
support management of JHS/EDS-HT in primary care did not consider psychological or 
social factors [22]. Understanding of these issues is vital in order to design effective 
interventions to support those with JHS/EDS-HT.  
Therefore, the overall aim of this study was to identify the psychosocial impact 
of JHS/EDS-HT by examining participants’ lived experiences, and to identify 
characteristics of effective coping with JHS/EDS-HT. 
Methods 
Methodology 
Qualitative research was chosen in order to gain a holistic, person-centred perspective 
from people with JHS/EDS-HT, allowing researchers to generate detailed accounts that 
give an active representation of that person’s reality [23]. In light of the potentially 
personal and in-depth nature of the research, where participants were anticipated to 
divulge information about the psychosocial impact of the condition on their lives, 
potentially including the recall of psychologically challenging experiences such as 
depression or anxiety, individual semi-structured interviews were chosen over focus 
groups. Semi-structured interviews permit the examination of social and personal 
matters in great depth, and can provide researchers with a significant advantage when 
exploring sensitive topics [24, 25]. Two authors (SB and SP) independently assessed the 
quality of the final manuscript using the consolidated criteria for reporting qualitative 
research (COREQ) framework; a 32 item checklist for reporting interviews and focus 
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Diagnoses in this study were self-confirmed, due to the remote telephone-based nature 
of the research. The Hakim and Grahame (2003) Five-item self-report questionnaire 
was used to screen for clinically significant hypermobility, as when a cut-off score of ≥2 
is applied it has high sensitivity (80-85%) and specificity (80-90%) to the cut-off score 
for hypermobility assessed physically (a Beighton score of 4 out of 9) [27]. 
 
Participants 
Adult participants were recruited through 1) advertisements on the Twitter and 
Facebook pages of the Hypermobility Syndromes Association (HMSA) and Ehlers-
Danlos Support UK (EDS-UK) and 2) recruitment through a local NHS Trust. Eligible 
participants were aged over 18, with a self-declared diagnosis of JHS, EDS-III or EDS-
HT, (due to variations in categorisation of Ehlers-Danlos Syndrome over time), who 
were able to understand and communicate in English, and gave informed consent. 
Participants with fibromyalgia were not excluded, as those with JHS are significantly 
more likely to self-report a diagnosis of fibromyalgia [28].  Respondents with a 
diagnosis of a different subtype of EDS or any other musculoskeletal disorder were 
excluded. Participants were purposively sampled using a sampling frame to select from 
particular representative characteristics, which can be particularly valuable in under-
researched populations [29] including age, gender, ethnicity and their five-item 
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hypermobility questionnaire score [25]. Pseudonyms have been used throughout to 
ensure confidentiality.  
 
Data collection: Conducting interviews 
Prior to study commencement, eligible participants were emailed to arrange the 
interviews at a time convenient to both parties, with the interview referred to as a 
‘friendly chat’ to reduce anxiety. Telephone interviews were conducted in a private 
office at the University of the West of England, Bristol between August 2016 and 
March 2017 by the first author (SB), a female PhD candidate with previous training and 
experience as a telephone-based emotional support helpline volunteer. Recording was 
achieved through use of a Dictaphone and in-line recording adapter, with participants 
reminded that the call was being recorded at the start of each interview. To put each 
participant at ease, the format and aims of the interview were explained, anonymity 
assured, and each participant was given the opportunity to ask any questions before the 
interview questions commenced [30, 31].  
Reflexivity 
As the first author (SB) has personal experience of EDS-HT and Postural Tachycardia 
Syndrome (POTS), this was made this clear to participants at the start of the interview. 
As an ‘insider’ to the world of Ehlers-Danlos, SB wanted to alter the power imbalance 
so often seen in traditional research [32, 33]. SB chose to reveal that she had EDS-HT, 
but emphasised that her experiences were likely to be very different from the 
participants, and it was their own stories that mattered. Westmarland [34] argued that 
sharing information about the self and reducing power can work towards creating a 
more relaxed experience. By acknowledging SB’s dual identity both as a researcher and 
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an individual with EDS, this appeared to instil greater confidence in participants and 
they seemed very willing to share with SB, a fellow ‘in-group’ member.  
 
Data collection and analysis 
The interviews followed the interview protocol outlined in Supplementary Table 2. 
These questions were developed using issues highlighted in previous JHS and EDS-HT 
literature as a guide, in addition to the results of a systematic review and thematic 
synthesis examining all qualitative JHS and EDS research to date [11]. Due to the 
exploratory nature of the study, the questions remained broad to allow participants to 
share their experiences. Questions were pilot-tested by the first author prior to the study, 
approved by the research team and a patient research partner, and refined as required 
during data collection to ensure clarity.  
The data were analysed by the first author using inductive thematic analysis 
(TA) as outlined by Braun and Clarke [35] and the analysis was reviewed and discussed 
with the other authors to ensure consensus. Inductive TA is a very flexible method that 
allows for a broad focus on meaning across a dataset, and is particularly suited to 
exploratory study [33]. The transcripts were double-checked for accuracy against the 
audio recording before being imported into NVivo 10 (QSR International, Melbourne, 
Australia). This software allowed a better, more efficient overview of the data, and 
allowed full and equal attention to each data item [35]. Initial data coding took place on 
an ongoing basis. When no new codes could be identified, data saturation was discussed 
and agreed with the other authors, and interviews stopped at 17 participants. In this 
case, saturation was defined as the point where similar answers were offered by 
participants to the questions, and the when analysis of additional data did not lead the 
researcher to identify any new codes [36, 37]. Once all the data had been initially coded 
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and organized, the codes were revised and re-organised into themes, which were 
derived inductively from the data. Different codes were combined to form themes, and 
this process revisited and revised, with some irrelevant and minor codes discarded, 
while others were promoted to overarching themes. 
Results 
Three hundred and eleven people responded initially, and of these, 145 participants 
responded to a request to complete the Hospital Anxiety and Depression Scale (HADS) 
[38]. Five of these did not meet the inclusion criteria, due to secondary medical 
conditions such as Marfan’s Syndrome. 140 participants were screened using a HADS 
cut-off score of 15. The score allowed participants with clinically significant anxiety or 
depression to take part, but prevented participants with severe expressions of either 
condition from being included (scores >15) [38, 39]. This excluded 26 potential 
participants, or 18.57% of the sample. A purposive sampling strategy was implemented 
for the 114 remaining prospective participants, where persons were purposively 
sampled based on criteria relevant to JHS and EDS-HT research. For each category 
(age, gender, ethnicity, 5PQ score and levels of anxiety and depression as measured by 
the HADS) participants in the list were randomly selected using a custom-range true 
random number generator.  
A total of 17 people (14 women, 3 men) took part in the study. All had a diagnosis of 
JHS/EDS-HT or EDS-III. Five participants (4 women, 1 man, 29.4% of the final 
sample) also had a diagnosis of Fibromyalgia, which is comparable to rates of 
Fibromyalgia in other JHS populations (27.3%, [28]; 30%, [40]). Twelve participants 
identified as ‘White’, four identified as ‘mixed White and Asian’, and one participant as 
‘mixed: White and Indian’. Five participants were from the South-East of England, 
three from the South-West, three from the Midlands, one from the North-West, three 
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from the North-East, and two from Scotland. Interviews lasted between 43 and 99 
minutes (with a mean duration of 74 minutes).  In the quotes below, pauses in speech 




Five overarching themes were identified through analysis of the interview data: 
(1) Restrictions imposed by JHS/EDS-HT 
(2) Healthcare limitations 
(3) Social stigma  
(4) Fear of the unknown  
(5) Ways of coping 
Each major overarching theme featured data from all 17 participants. These are 
presented below, with illustrative quotes as appropriate. Data illustrating theme and 
subtheme frequency counts to indicate the representativeness of the findings across the 
data is listed in Supplementary Table 3. To ensure participant confidentiality, 
pseudonyms have been used throughout. 
Theme 1: Restrictions imposed by JHS/EDS-HT  
Many participants described limitations in their daily activities due to factors such as 
frequent dislocations, restricted mobility and symptoms of fatigue and pain. The 
patellae, shoulders, jaw and hips were cited as the most often dislocated, but potentially 
any joint was at risk.  Problems with swallowing and digestion limited participants’ 
ability to maintain a ‘normal’ social life. The majority had problems completing 
housework, cooking, shopping or dressing. 
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Some participants also reported difficulties with sex and intimate relationships. 
These problems seemed to stem from issues around fatigue and pain, as Nigel explains: 
“I'm always so tired, or I'm aching somewhere, you can't really get in the mood….” 
Jake found it “very difficult … to talk about things like erectile dysfunction”, later 
reflecting that there was little his doctor could do to help. For women, gynaecological 
complications such as prolapse could have a similarly distressing impact, as Jackie said: 
“You don't want anyone to come anywhere near you”. These difficulties led to worry 
regarding relationships with their partners. Nigel was fearful that his wife might leave 
him: “Is she going to be understanding …[for] The rest of our time together?… It's a 
big thing, not having…the sexual side of a relationship”.  
Relying on others  
To complete the tasks that they couldn’t manage, participants sometimes had to rely on 
others for support. However, this left them feeling guilt, like “a burden” [Roger], with 
fears that they were “restricting” [Roger] or holding back [Frances] their family 
members. Over time, worries about their responsibilities could lead to exacerbations of 
anxiety and depression, as Roger describes: “Sometimes I feel a burden, or a nuisance… 
that’s why I end up…having the anxiety problems … feeling sorry for other people, 
having to put up with me”.  
Work life and education  
The majority of participants had started their working lives without a diagnosis of 
JHS/EDS-HT. Many had initially worked in roles that were not suited to their condition 
and were forced to re-think their career options. In an effort to manage fatigue, 
participants worked reduced hours, or from home. Working was cited as very important 
to participants; they felt that work gave them a role in society and a purpose in life, 
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which in turn benefited their emotional wellbeing: “Even if I don’t get (.) any money or 
anything, at least I'm doing something useful” [Rachel]. Anna emphasised the need to 
stay positive, despite the potential restrictions to her work life: “for my wellbeing I feel 
that I need to be doing something…So I try to keep working…to try and keep myself 
positive”.  
Theme 2: Healthcare limitations 
Lack of awareness of JHS/EDS-HT  
Every participant interviewed reported an overall lack of awareness of hypermobility 
syndromes such as JHS/EDS-HT among healthcare professionals, including consultants, 
General Practitioners (GPs), nurses and physiotherapists. This naturally resulted in 
patients waiting many years to be diagnosed. Others were labelled as “hypochondriac”, 
several as “making it up”, some as the symptoms being “all in your head”, or accused 
of having a mental health problem. However, after many instances of being mislabelled 
as hypochondriacs, several participants described their diagnosis as a positive, 
validating experience, as years of symptoms were finally given a recognized cause: 
“…it all makes sense now… you realise you're not going mad!” [Claire]. 
Just bendy joints 
However, even with a verified diagnosis, some felt that their symptoms were still 
dismissed by healthcare professionals as, “just bendy” [Mandy], rather than seeing the 
wider psychosocial impact of the condition on participants’ lives. One participant, 
Mandy, reflected on whether her consultant’s attitude was due to a lack of 
understanding about JHS/EDS-HT:“Even if they've heard of EDS, it's 
misunderstood…’Yeah, you got bendy joints’ … And it's like, ‘Yeah, but there's a bit 
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more to it than that!’”. 
Almost all participants gave examples of healthcare professionals’ negative 
reactions and attitudes, such as becoming angry or being dismissive of their symptoms. 
Others spoke of feeling objectified during medical examinations, with their 
hypermobility treated as a spectacle. Frances gives an example: 
…Then [Doctor] was like, ‘Wow! You’re such a freakshow!’, and I'm like (.) ‘Wow. 
Not a nice thing to say, thanks!’ …[He said] ‘Ooh, let's get all the medical students 
here and show them!’ And I'm like, ‘No!’ 
Limitations of current treatment 
A significant number of participants described instances where local anaesthetics had 
been ineffective due to their hypermobility syndrome. This can result in patients 
undergoing surgical and dental procedures fully aware of pain: “I could feel what they 
were doing. And I- I spoke up, and (.) [the doctor] basically said, ‘No, you can’t.’ and 
carried on… but I was in a lot of pain?” [Mandy]. 
Nigel and Bryn had both made attempts to warn their surgeons during subsequent 
procedures, but to little success:  
 
“and the surgeon said, ‘What's Ehlers-Danlos?’” [Nigel] 
 
“They [had] no idea” [Bryn].  
A combination of dismissive attitudes from healthcare professionals, and a lack of 
treatment options had made Rachel wary: “I just want to keep away from doctors if I 
can… unless its desperate I won't bother.”. 
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Theme 3: Social Stigma  
Difficulty keeping up  
Difficulty in keeping up with friends, family and colleagues led to feelings of frustration 
and anger in participants, because their joints could not always endure what they wanted 
to do, as Nigel describes: “Why can't I do what everybody else does? Why am I the only 
one who can't (.) Go for this walk?’ You know? ‘Do this thing that everyone else is 
doing?”. 
Participants described a number of internalised negative feelings about their own 
bodies. Several described themselves as “weird” or “useless”, experiencing shame and 
guilt. Rhiannon expressed a longing to be “normal”: “I guess made me (long pause, 3 
seconds) a little bit? Frustrated with my body? That it can’t be a bit more normal.”. 
Judgements of others 
Due to the invisible nature of JHS/EDS participants often faced judgements from 
friends, family and strangers, as Jackie states: “I’ve also gotten abuse off of disabled 
people? …‘why are you parking in a blue badge space?’”. 
  Many described feelings of embarrassment, guilt and shame when confronted by 
others. Participants mentioned ‘you look well’ [Tabitha], ‘I’m a younger person’ 
[Claire], ‘I’m the one who looks less disabled’  [Dana] or ‘you look fine’ [Nigel] as 
potential reasons why they had been stopped. Mandy questioned whether this 
judgement was due to those with JHS/EDS-HT not fitting the common perception of 
disability as a visible difference: “But, other people's judgement…if you don't fit that (.) 
Notion of what disabled is in their head, then they get really confused.”.  
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Hiding symptoms from others 
Fears of being judged led many to hide their symptoms, in an effort to “pretend it's 
okay” [Nigel]. Participants expressed hesitancy in being perceived as ‘faking things’ 
[Jackie] or ‘as if you’re complaining the whole time [Tabitha]. Lauren mentioned a need 
to “Try and appear normal all the time”. Many believed that other people might think 
negatively of them if they knew about their JHS/EDS-HT. Divulging their invisible 
difference to others took a great deal of confidence, yet others described feeling 
embarrassed when asking for accommodations such as a seat on a busy train, “People 
are judging me.’ and I just kind of want to (.) get on quietly and I’ll skulk away” 
[Mandy].  
Men in the present study felt that the need to ask for seats had ‘chipped away’ at 
their masculinity. Some wondered whether their JHS/EDS-HT would be more readily 
accepted by others if it were more visible, as Jackie recounted: “I actually wish I was in 
a wheelchair! Do you know what I mean? I just feel like (.) People can understand 
that?”. 
  Numerous participants found the invisible nature of their condition an asset, 
preferring not to ‘let [JHS/EDS-HT] define me’ [Wendy]. Similarly, other participants 
felt that they could choose when to bring up their disability, and how. Choosing what 
and when to tell others about their condition afforded participants a sense of control. 
However, the effort of hiding differences from others can be psychologically 
demanding over time. 
Theme 4: Fear of the unknown  
Fears of future decline 
Not knowing when the next injury was going to occur, how their illness trajectory was 
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going to affect them over time, or the potential impact of JHS/EDS on their future plans 
made participants especially fearful of future declines in their physical ability. Others 
described feelings of panic that they still had not achieved everything that they wanted 
to do: 
It's genetic…we can't fix this, what does this mean for the future?... You know? ‘I'm 
not going to be able to get married, or have kids’, all the things that I thought I 
would. [Mandy] 
For participants with a family history of JHS/EDS-HT, their parents’ struggles were a 
vision of their own future, as Frances described: “All the things I can do now, [Mum] 
could do when she was my age…But now, she needs a double knee replacement because 
her knees are just so worn out?”. 
Fears of future decline linked to Roger’s worries about depending on other 
family members, and feelings of guilt, shame and being a burden on his loved ones: “I 
still am- frightened of what the future holds... one day I might not be able to do 
anything. And it’s that fear of being a burden again?”. 
Many participants took the initiative to find out more about their condition, and 
had joined support groups and a variety of social media pages. However, seeing others 
with JHS/EDS-HT, in person and online, who were more severely affected than 
themselves sometimes led to a cycling progression of fears concerning prospective 
future declines in ability. These fears led to fearful responses to new or unusual 
symptoms, as participants became anxious as to whether the new symptom signalled 
their own health decline: 
Some of the stuff on the internet…- it fills your head with fear in some respects… 
and I’m like, ‘Ah! I don’t want to end up like that!’. It’s that fear that, ‘Ah, that 
could happen!’…over-thinking things and then I start panicking, it’s like, then it’s 
a vicious circle. [Roger]  
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While others felt that social media could lead to competition: “Even in the EDS 
community… People almost sort of, trying to outdo each other, with, ‘Oh, look how ill I 
am, look how it impacts on my life.’” [Tabitha]. 
 
Lack of reliable information 
Many spoke of a lack of reliable information about their condition. All accepted the 
need to gain information about JHS/EDS-HT from reputable sources such as patient 
support groups, rather than “just picking up things on forums” [Roger]. However, 
participants recognised that not everyone with JHS/EDS-HT would have access to 
trustworthy information: “And I think there’s a lot of… misinformation out there as well 
I think …There doesn’t seem to be a huge amount of research into it, or information?” 
[Rhiannon]. 
 
Pregnancy and heritability 
Participants’ fears for the future also applied to decisions about having children. Due to 
the hereditary nature of JHS/EDS-HT, participants considering future children were 
worried about whether their children would inherit JHS/EDS-HT from them: “But yeah. 
It's always that fear (.) Of passing it on, and seeing someone else have to go through, 
what I've gone through?” [Roger]. 
Many of the participants in the present study had been diagnosed with JHS/EDS-
HT much later in life. Some who had found out about their condition years after having 
families had faced many issues: 
Because [EDS-HT] wasn't picked up I've had (.) premature babies and (.) extensive 
problems during pregnancy, life-threatening miscarriage and things like that… if 
I'd known the complications, and the risks, of having a baby, then I probably 
wouldn't have gone on to have four. [Anna] 
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Others struggled with the guilt of having unknowingly passed JHS/EDS-HT on 
to their children: “If I’d have known, I wouldn't have inflicted this on anyone.” 
[Lauren]. Mandy described the guilt felt by her mother: “When I first got diagnosed, I 
think my mum had felt quite a bit of guilt? Um, partly the (.) Hereditary thing, thinking 
she's passed it on.”  
Perceived lack of psychological support 
Some felt that psychological support to better cope with the stress and enduring 
psychosocial impact of JHS/EDS-HT on their lives was lacking: 
“What I would say is that nobody … considers the psychological impact… I got 
diagnosed, and then was basically just told- …‘Well, this is just going to get 
worse.’ And then you get sent away! And no-one seems to think they’ve just given 
you a life-changing diagnosis. [Jackie] 
 
…how it affects you emotionally… I think that can get forgotten by doctors, 
sometimes…or at least it's not looked at as a whole package, necessarily.”[Wendy] 
Neither Jackie nor Wendy felt that the psychological or emotional impact of 
JHS/EDS-HT was taken into account. Others wished for support when stressed, 
depressed or anxious; to address their fears about the future and worries about potential 
declines in their condition.  
Theme 5: Ways of coping 
Psychosocial and cognitive appraisals: Acceptance 
Many cited acceptance of the life-long nature of their condition as having a beneficial 
impact, and acknowledged receiving a diagnosis as part of that. By recognising the need 
to pace activities and “stay in sometimes because I just can't (.) Do everything.” 
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[Georgina], participants were better able to manage the psychosocial impact of 
JHS/EDS-HT on their lives. As Frances stated: “I think now, I'm like, ‘Do you know 
what? I'm weird, and I'm bendy, and I'm always going to be that way, nothing is going 
to change how I am now.’”. Acceptance of a chronic condition, including its 
implications and limitations, seemed to give participants a sense of control. Numerous 
participant cited the need to be optimistic, and staying ‘positive’ in the face of repeated 
flare-ups and setbacks was also emphasised: “Okay, that's how I am at this point in 
time, but tomorrow is another day…do something that makes you smile.” [Lauren]. By 
downwardly comparing themselves to others who had more severe JHS/EDS-HT or 
other life-limiting conditions, many participants felt that life “could always be worse” 
[Roger] and chose to see the positives in their own situation: “‘I'm still fine, I'm still 
alive, there are worse things that I could have’, you know?” [Frances]. Although 
JHS/EDS-HT had limited Frances’ ability to ‘keep up’ with her friends socially, she 
found that she could “still do stuff that I enjoy and have fun”. Many spoke of the need 
to harness their determination, to “find a way” to complete the goals they had set their 
mind to. As Jackie explained: “rather than just accepting ‘no’. ‘Is there a different way 
I can do this?’”. 
Social support 
As friendship groups shifted, many participants made friends with, and gained social 
support from people with JHS/EDS-HT or other chronic health conditions. Participants 
perceived these ‘similar’ friends as more understanding and empathetic to what they 
were going through. As Georgina put it: “…the friends I do have now are the ones that 
are similar to me, not necessarily hypermobile but they’ve got mild disabilities. So they, 
at least, can relate.”. The combination of social support and finding out more about 
JHS/EDS-HT gave participants the confidence and assertiveness to explain and educate 
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others about their condition when challenged: 
So yeah, [when people don’t understand] doesn’t particularly frustrate me. I see it 
as more of a chance to educate people about EDS and other invisible illnesses. I’m 
really happy to talk about it. As I say, you start me off on it and I never shut up! 
[Wendy] 
Physical and Behavioural :Hobbies and projects 
Participants cited various hobbies and projects as a way to keep themselves ‘sane’ 
[Nigel]. Nigel had always really enjoyed DIY and got great enjoyment from hands-on 
building projects, but the impact of such activities left him ‘completely ruined’ for 
weeks after. Later, he found a good substitute to give him the same level of happiness 
and satisfaction, which he felt occupied his mind from ‘dwelling on things’:  
It's Lego… because I can do that sitting down, I haven’t got to, you know, expend 
too much energy by doing it…it’s helped my- my self-esteem, and my mental side of 
it, more than anything. [Nigel]  
Positive interactions with healthcare professionals  
Although participants reported that some recommended exercises made their pain 
worse, others had reported very positive experiences of physiotherapy. These were 
physiotherapists who had specialist JHS/EDS-HT knowledge, who could provide 
emotional support and encourage regular exercise: 
She’s shown me techniques … how to put [subluxations] straight back before it 
comes out and things like that. So I’m not as, frightened in some respects? There’s 
a bit more light at the end of the tunnel. [Roger] 
While they may not always recognise the condition, participants were pleased 
when clinicians were willing to learn: As Jake put it, “it’s more… how they respond to 
NOT knowing, than what they know.” While it was acknowledged that GPs could not be 
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expected to know everything about rare genetic disorders, participants felt that greater 
training and awareness of JHS/EDS-HT among healthcare professionals could improve 
outcomes for patients.  
Often, it was not that a treatment had worked, but that healthcare professionals 
had taken the time to listen compassionately and empathetically to patients “rather than 
just (.) Pacifying you, and sending you away.” [Mandy]. By acknowledging the holistic, 
multidisciplinary impact of JHS/EDS-HT and providing useful guidance, healthcare 
professionals could prevent participants from feeling that their condition was not 
recognised. 
Discussion 
This study provides a novel understanding of how psychosocial factors, such as the 
support of family, social networks and attitudes of healthcare professionals are 
perceived to play significant roles in shaping men’s and women’s experiences of 
JHS/EDS-HT.  
Invalidation can be a common problem with rheumatic diseases [41], and 
involves a lack of understanding or negative social responses from others, such as 
disbelief, rejection, stigmatization and suspicion that the problem may be psychological 
in origin [41]. In line with other examples within the literature, participants in this study 
experienced very long waits for diagnosis, allegations of hypochondria or malingering, 
and a lack of understanding and knowledge of the condition from healthcare 
professionals [12, 13, 15, 42, 43].  
Pain and fatigue, the main symptoms in JHS/EDS-HT, are mostly non-
observable by others; therefore participants’ symptoms and the associated burden of the 
condition were often cited as being poorly understood. Participants in the present study 
hid their symptoms in an attempt to appear ‘normal’ and avoid confrontation.  Shame, 
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guilt and stigma can have negative psychosocial consequences, lowering self-esteem 
and in some cases leading to depression [44]. Interventions to address issues around 
self-esteem in chronic pain populations have targeted social functioning, including 
issues such as as anger management, dealing with depression, uncertainty and self-
esteem [45, 46]. Therefore, future psychosocial interventions and support to address 
feelings of stigma and improve self-esteem would be valuable.  
Others recounted significant pain from reduced effectiveness of local 
anaesthetics, thought to be due to the underlying collagen defect in JHS/EDS-HT [47]. 
These negative experiences could lead to a fear of treatment, which may prevent those 
with JHS/EDS-HT from seeking appropriate medical care [12]. When finally diagnosed, 
participants reported feeling great relief at understanding their condition, in line with 
JHS/EDS-HT research [14, 43] and other difficult-to-diagnose conditions [48]. Some 
progress is already being made towards improving awareness of JHS/EDS-HT amongst 
general practitioners through a newly published EDS GP Toolkit, in partnership with 
the Royal College of General Practitioners (RCGP) and a patient support group, Ehlers-
Danlos Support UK (EDS-UK) [22]. However, there is still an overall lack of training 
and awareness of JHS/EDS-HT among GPs and healthcare professionals, and the 
guidance does not cater for the psychosocial impact of the condition. 
In addition to difficulties with local anaesthetics, recent important research by 
Rombaut et al [49]  and Scheper and colleagues [50] also indicated significant 
hypersensitivity to pain in patients with JHS/EDS-HT, compared to the general 
population. Generalised hyperalgesia, defined as an abnormally increased sensitivity to 
pain, has been tested using pressure-pain thresholds, (PPT’s) at a range of body areas in 
patients with EDS-HT compared to control participants [49, 50]. Results revealed that 
those with EDS-HT to have significantly lower thresholds compared to the control 
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group, even in non-symptomatic areas of the body, indicating generalised hyperalgeisia 
[50]. These results suggest the possibility of central nervous system sensitisation, 
hypothesised as being due to the collagen defect affecting the axonal function of 
peripheral nerves in JHS/EDS-HT, which could leave this population more prone to 
chronic pain and fatigue [8, 49]. Therefore, the tailoring of multidisciplinary pain 
management interventions, including cognitive behavioural therapy and physiotherapy 
would be an important consideration, in order to reduce overall disability and improve 
patient quality of life [49]. 
Participants with JHS/EDS-HT experienced numerous restrictions to their lives 
as a result of a range of symptoms, including pain, fatigue and the unpredictability of 
their condition. Due to the multisystemic nature of JHS/EDS-HT, participants can 
experience a number of additional health problems such as functional gastrointestinal 
issues, urinary problems and autonomic dysfunction [51]. These additional 
multifactorial symptoms, in combination with environmental factors such as social 
stigma or isolation may contribute to psychological distress and disability in this 
population [52]. 
 Issues around the effects of pelvic organ prolapse in JHS/EDS-HT echo a recent 
questionnaire survey which found more severe sexual dysfunction and a greater 
negative impact on quality of life in women with JHS compared to the general 
population [53]. Difficulties with sexual relationships due to vaginal or bladder prolapse 
in women, or erectile dysfunction in men are an under-researched finding; participants 
feared a negative impact on their relationship, and were unsure of what could be done 
medically to solve their problems. Erectile dysfunction can also be a symptom of 
autonomic dysfunction, a common co-occurring diagnosis in JHS/EDS-HT. Autonomic 
dysfunction has also been linked to sexual dysfunction in Parkinson’s disease [54]. 
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However, there has been little assessment of this issue within the JHS/EDS-HT 
literature. In JHS/EDS-HT research populations women typically outnumber men, and 
in a recent study of autonomic dysfunction symptoms, the majority of men with EDS-
HT did not want to complete the erectile dysfunction symptom profile, so its impact was 
not recorded [55]. These results indicate the need for greater support and recognition of 
potential intimacy issues in JHS/EDS-HT, particularly for health professionals in 
primary care, as problems with sexual functioning may markedly influence the patient’s 
quality of life.  
A scarcity of information and dependable psychological support for JHS/EDS-
HT led some to be very fearful of future declines in their ability. In addition the 
potentially negative influences of finding information on the internet were also 
highlighted by participants, and are a new consideration in this area. Several 
participants described these fears as leading to catastrophizing and feelings of panic 
when faced with new symptoms, in case this signified their own decline [56]. In 
addition, when people make social comparisons to others in the same chronic illness 
group there is a risk that other support group members’ decline could be interpreted as a 
representation of their own future, resulting in negative feelings [57, 58, 59, 60]. Due to 
the hereditary nature of the condition, this is particularly relevant to children whose 
parents also have JHS/EDS-HT. Psychosocial factors such as fear-avoidance 
behaviours, activity limitation, catastrophizing and fear of movement may substantially 
contribute to increased levels of disability in this patient group, as has been seen in 
other chronic pain populations [61, 62]. In this case, maladaptive beliefs relating to 
JHS/EDS-HT (such as the belief of a sudden decline) appeared to lead to heightened 
emotional reactivity, leading to catastrophizing, anxiety and feelings of panic [62]. In 
order to counteract this effect, it may be beneficial for support group members to be 
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provided with opportunities for positive social comparison, as interaction with other 
patients has been shown to help reduce fear relating to symptoms [63]. Modelled 
behaviour involves providing example behaviours for people to aspire to or imitate [64]. 
With links to Bandura’s Self-Efficacy Theory, self-efficacy relates to an individual’s 
expectations and beliefs about their ability to perform specific actions effectively [65]. 
Video modelling, or the demonstration of desired behaviours through visual media, has 
been used successfully in patient education and to facilitate learning of new skills [65], 
including prostate [66], breast [67] and colorectal [68] cancer screening, and adherence 
to self-care behaviours for participants with heart failure [69]. By using models to 
promote exemplary behaviours, video modelling can serve as a useful way to promote 
self-efficacy in others [70]. For instance, examples of self-help ideas and positive 
coping strategies could be promoted by those with JHS/EDS-HT using video clips, for 
people experiencing a flare in symptoms. 
These results also demonstrated the physical and psychosocial impact of 
JHS/EDS-HT in terms of adjustment and adaptation to the condition, extending 
knowledge regarding coping strategies employed by those with JHS/EDS-HT. Initially, 
diagnosis was met with relief, but later reactions indicated that participants had to face 
changes in how they saw themselves, and how others perceived them, reflecting a 
period changes to their identity. These results are similar to other research indicating 
that chronic illness and disability can bring about great changes in a person’s identity 
[71]. Many cited acceptance of JHS/EDS-HT as positively influencing their ability to 
cope. Acceptance in this case can be defined as refocusing attention on aspects of the 
condition that they can control, rather than struggling to control pain [72]. These 
findings are similar to those of other studies, which found that acceptance promoted 
adjustment to chronic disease [73, 74, 75]. In addition, rheumatic diseases research has 
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indicated that acceptance of a pain condition, in addition to high self-efficacy, can have 
a buffering effect against invalidation by others, such as healthcare professionals, 
friends or family [76].  Participants who identified a need for greater psychological 
support indicated that this should be available as soon as possible following diagnosis in 
order to better support this process and transition.  
Building social networks and social support were also cited as useful coping 
strategies by participants, including joining support groups and making friends with 
others who had JHS/EDS-HT. Online and face-to-face support communities play an 
important role for those with chronic diseases in conveying information, gaining 
emotional support and comparing experiences [77, 78]. Social comparison theory may 
be useful in understanding how these comparisons influence quality of life. Downward 
social comparison, the comparison of the self to someone doing less well, has been 
associated with improved quality of life [79], and can be used to enhance positive affect 
[80]. By gaining knowledge about their condition, participants were able to foster a 
sense of control, and lessen the feelings of ‘unknown’ and fear that can be present in 
unpredictable conditions [75, 81]. 
In line with prior research [12, 15, 16] participants described how becoming 
dependent on others for help with activities could result in feelings of guilt and shame. 
This highlights a need for greater support for participants with JHS/EDS-HT in order to 
maximise independence in everyday activities, particularly in relation to personal care, 
washing and dressing. This is a key indication that rehabilitation and support for people 
with JHS/EDS-HT needs a greater focus on maximising independence in activities of 
daily living.  
Many participants actively adapted hobbies and sports to better achieve their 
ambitions. Healthcare professionals such as physiotherapists with knowledge of 
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JHS/EDS-HT were cited as helping them to achieve their goals. By giving patients an 
indication that things could improve, physiotherapists gave patients hope. Encouraging 
patients to adjust to daily life may lead to a sense of control and stimulate active coping 
strategies. A recent qualitative study of physiotherapy for JHS recommended a holistic 
approach to management, rather than treating single joints in isolation [17]. Specialist 
physiotherapists with knowledge of JHS were cited as being very helpful. However, 
specialist physiotherapy is limited in the UK, and there is little consensus regarding 
optimal exercise [82]. Further exploration of patient and healthcare professionals’ ideas 
about optimising supportive interventions for JHS/EDS-HT would be valuable.  
Strengths and Limitations 
This is the largest study of participants’ lived experiences of JHS/EDS-HT, compared to 
previous semi-structured interview studies (n=10, [15]; n=11 [12, 16]). In addition, this 
study had a proportionally higher representation of participants of mixed ethnicity. 
While hypermobility is known to affect Black and Asian populations to a greater extent 
[5], very few ethnically diverse participants have been involved in JHS and EDS 
research compared to participants of White ethnicity. While this study purposively 
sampled to gain a broader representation, further work is still required to assess whether 
any new themes would be identified with greater representation of black and minority 
ethnic populations, whose views in JHS/EDS research have yet to be explored in great 
depth. In addition, while men were involved in this study, their experiences of 
JHS/EDS-HT compared to women have yet to be fully studied.  
In addition, while the position of the first author (SB) as both a patient and a researcher 
could be considered a strength, the authors were also aware of the possibility of bias as 
a result of this dual position. While bias cannot be eliminated entirely, it can be 
mitigated [83]. In order to counteract this, the first author (SB) kept a reflective practice 
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research diary exploring her feelings and reflections after each interview. A random 
selection of recordings was checked against transcripts by the research team (NW, TM, 
SP), thereby allowing those not directly involved in data collection to audit the results, 
reducing potential bias and ensuring accuracy [83]. In addition, peer debriefing was 
used to safeguard externality, where the research team (NW, TM, SP) reviewed the 
findings and themes identified in the results. This allowed the first author the chance to 
think more critically about the research, and to discuss and explore judgements made 
about the data. 
Implications for clinical practice 
These findings have built upon previous findings in this area, including sexual 
dysfunction [84], and requirements for improved awareness among healthcare 
professionals [13, 14, 16, 43]. New topics have also been established, such as a need for 
greater independence in activities, fear regarding symptoms and decline, and the risk 
associated with social comparisons to others with JHS/EDS-HT.  The importance of 
social support, patient groups and communities was highlighted, as was the need for 
future interventions to improve feelings of stigma and boost self-esteem. It would be 
helpful to map what is now known about the psychosocial impact of JHS/EDS-HT to 
behaviour change theories, such as the Theoretical Domains Framework or COM-B [64, 
85]. This could help to develop focused behaviour change interventions based around 
factors identified by patients as promoting or hindering their ability to cope with 
JHS/EDS-HT. 
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Supplementary Table 1: Consolidated criteria for Reporting Qualitative Research 
(COREQ) checklist.  
Tong, A., Sainsbury, P., & Craig, J. (2007). Consolidated criteria for reporting qualitative research 
(COREQ): a 32-item checklist for interviews and focus groups. International Journal for Quality in 




Guide questions/description Reported on 
page 
number/section 
Domain 1: Research team and reflexivity 
Personal characteristics  































Relationship with participants 
Relationship 
established 






of the interviewer 
7 What did the participants know about the 
researcher? E.g. personal goals, reasons for 




8 What characteristics were reported about the 
interviewer/facilitator? E.g. bias, assumptions, 
reasons and interests in the research topic 
Reflexivity 
Doman 2: Study design 
Theoretical framework 
Methodological 
orientation and theory 
9 What methodological orientation was stated to 
underpin the study? E.g. grounded theory, 
discourse analysis, ethnography, 





Sampling 10 How are participants selected? E.g. purposive, 




Method of approach 11 How were participants approached? E.g.  face-





Sample size 12 How many participants were in the study? 17 participants: 
Results section 





Setting of data 
collection 





15 Was anyone else present besides the participants 
and researchers? 
N/A 




Interview guide 17 Were questions, prompts, guides provided by 
the authors? Was it pilot tested? 
Data collection 
and analysis 
Repeat interviews 18 Were there repeat interviews? If so, how many N/A 
Audio/visual 
recording 
19 Did the research use audio or visual recording to 
collect the data? 
Data collection 
and analysis 
Field notes 20 Were field notes made during and/or after the 
interview or focus group? 
N/A 
Duration 21 What was the duration of the interviews or 
focus group? 
Results section 
Data saturation 22 Was data saturation discussed? Data collection 
and analysis 
Transcripts returned 23 Were transcripts returned to participants for 
comment and/or correction? 
N/A 
Doman 3: Analysis and findings 
Data analysis  
Number of data coders 24 How many data coders coded the data? Data collection 
and analysis 
Description of the 
coding tree 
25 Did the authors describe a description of the 
coding tree? 
No 
Derivation of themes 26 Were themes identified in advance or derived 





Software 27 What software, if applicable, was used to 
manage the data? 
Data collection 
and analysis 




Quotations presented 29 Were participant quotations presented to 
illustrate the themes/findings?  








Data and findings 
consistent 
30 Was there consistency between the data 
presented and the findings? 
Yes, we think 
so. 
Clarity of major 
themes 
31 Were major themes clearly presented in the 
findings? 
Yes, we think 
so. 
Clarity of minor 
themes 
32 Is there a description of diverse cases or 
discussion of minor themes? 
Yes, we think 
so. 
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• Can you clarify for me whether your diagnosis is 
joint hypermobility syndrome (JHS) or Ehlers-Danlos 
Syndrome (EDS-HT) (or both)?   
• How did you come to be diagnosed? How long was it 
before you first started having symptoms and 
receiving your diagnosis?  
• What age were you at diagnosis?  
 




• What are your symptoms?  
• Do you have physical symptoms e.g. subluxations or 
dislocations, or fatigue?  
• How do you manage your day-to-day activities?  
• Do any activities make your symptoms worse? What 
happened?  
• What impact does JHS/EDS-HT have on your 
education and/or your work life? Has having 
JHS/EDS-HT had any impact on your relations with 
other people, such as friends or family?  
• What impact has JHS/EDS-HT had on your social 
and leisure activities?  
 
Impact on the 
individual, or on the 
perception of the self 
 
• Has having JHS/EDS-HT had an emotional impact?   
• How do you feel about having JHS/EDS-HT?   
• Has having JHS/EDS-HT changed how you think or 
feel about yourself?  
• Have they been any positive impacts of having 




• Is there anything that you have tried that has had a 
beneficial impact on your condition? e.g. Physical 
(such as exercises, physiotherapy, Pilates, yoga, 
gymnastics etc.), or emotional (e.g. relaxation, 
mindfulness, cognitive behavioural therapy, pain 
management programmes)?   
• Can you say what it is about these methods that 
helped?  
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• If you had to give advice to another person about 
how to cope well with JHS/EDS-HT, what would that 
be?  
• Have you taken steps to educate yourself about 
JHS/EDS-HT and find out more about your 
condition? Why/why not? 
 
Individual’s 
perceptions of others 
 
• Some research has suggested that JHS/EDS-HT are 
poorly understood conditions, whereas others have 
more positive experiences. What are your views on 
this?  
• Have you had any difficulties, or benefits, from the 
'invisible' nature of JHS/EDS-HT? What have these 
difficulties or benefits been?  
• Who were these with (e.g. family, friends, co-





• What have been your experiences of healthcare 
professionals, e.g. physiotherapists, occupational 
therapists, nurses, GP's, consultants, psychologists?  
• What kinds of treatment have you been offered?  
• Did your treatment change following your diagnosis? 
S 
• ome research has suggested that healthcare 
professionals can struggle to know how to treat 
patients with JHS/EDS-HT, whereas others seem to 
be more confident, I wonder which is closer to your 




• Is there anything else about your experiences, 
thoughts or feelings of living with JHS/EDS-HT that 
I haven’t mentioned?  
• Any questions that you thought I would ask, or 





Supplementary Table 3: Frequency counts for each theme and subtheme 
 
Each major overarching theme featured data from all 17 participants.  
 
The frequency counts for coding in relation to each participant are presented below. All 
major themes featured data from all 17 participants, as did the subthemes ‘lack of 
awareness of JHS/EDS-HT’, ‘difficulty keeping up’, judgements of others’.  
 
Supplementary Table 2: A table to illustrate the representativeness of the findings 
across the data. 
 
Theme and subtheme 
Number of 
transcripts coded to 
the theme or 
subtheme (n=17) 
Theme 1: Restrictions imposed by JHS/EDS-HT  17 
• Relying on others 9 
• Work life and education 11 
Theme 2: Healthcare limitations  17 
• Lack of awareness of JHS/EDS-HT 17 
• Just bendy joints 12 
• Limitations of current treatment 12 
Theme 3: Social Stigma 17 
• Difficulty keeping up 17 
• Judgements of others 17 
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• Hiding symptoms from others 14 
Theme 4: Fear of the unknown 17 
• Fears of future decline 13 
• Lack of reliable information 7 
• Pregnancy and heritability 9 
• Perceived lack of psychological support 3 
Theme 5: Ways of coping  17 
Coping: Psychosocial and cognitive appraisals 17 
• Acceptance 12 
• Social support 15 
Coping: Physical and Behavioural 17 
• Hobbies and projects 14 
• Positive interactions with healthcare professionals 15 
 
